Gliminyle-MV1 Tablet SR

Gliminyle-MV1 Tablet SR is a combination medicine used to treat type 2 diabetes mellitus. It contains Glimepiride (1mg), Metformin (500mg), and Pioglitazone (15mg). This triple-drug combination works together to control blood sugar levels in adults who cannot manage diabetes through diet and exercise alone. It improves insulin sensitivity, reduces glucose production in the liver, and helps the pancreas release more insulin. Regular use of Gliminyle-MV1 Tablet SR helps lower the risk of diabetes-related complications like heart disease, kidney problems, and nerve damage.

Uses of Gliminyle-MV1 Tablet SR

• Manages type 2 diabetes mellitus in adults
• Helps reduce high blood sugar levels
• Prevents long-term diabetes-related complications
• Supports better insulin response and glucose control

How Gliminyle-MV1 Tablet SR works

Gliminyle-MV1 Tablet SR combines three anti-diabetic agents: Glimepiride increases insulin secretion, Metformin lowers sugar production in the liver, and Pioglitazone improves the body’s sensitivity to insulin. Together, they effectively control blood glucose levels in type 2 diabetes.

Benefits of Gliminyle-MV1 Tablet SR

• Triple action formula for better blood sugar control
• Reduces insulin resistance
• Helps in long-term diabetes management
• Lowers the risk of complications such as nerve and kidney damage

How to take Gliminyle-MV1 Tablet SR

Take Gliminyle-MV1 Tablet SR exactly as prescribed by your doctor, usually once or twice daily with meals. Swallow the tablet whole with a glass of water. Avoid skipping meals to prevent low blood sugar. Do not take more than the recommended dose, and monitor your blood sugar regularly during treatment.

Side effects of Gliminyle-MV1 Tablet SR

• Low blood sugar (hypoglycemia)
• Weight gain
• Swelling or fluid retention
• Stomach upset, nausea, or diarrhea
• Headache or dizziness
• Lactic acidosis (rare but serious)
• Liver function changes (rare)

Safety advice

• Not suitable for type 1 diabetes patients
• Avoid alcohol to prevent low blood sugar and lactic acidosis
• Inform your doctor if you have kidney, liver, or heart problems
• Do not use during pregnancy or breastfeeding without medical advice
• Use cautiously in elderly patients
• Regularly monitor blood sugar and kidney function

Frequently Asked Questions (FAQs)

Q: What is Gliminyle-MV1 Tablet SR used for?
A: Gliminyle-MV1 Tablet SR is used to control blood sugar levels in adults with type 2 diabetes who do not respond well to single or dual therapy.

Q: Can I take Gliminyle-MV1 Tablet SR on an empty stomach?
A: No, it should be taken with food to reduce the risk of stomach upset and low blood sugar.

Q: What should I do if I miss a dose?
A: Take the missed dose as soon as you remember. Skip it if it's almost time for the next dose. Do not take two doses at once.

Q: Is Gliminyle-MV1 Tablet SR safe for long-term use?
A: Yes, when taken as prescribed and monitored by your doctor, it is effective for long-term diabetes management.

Q: Can I drive after taking Gliminyle-MV1 Tablet SR?
A: If you feel dizzy or experience low blood sugar symptoms, avoid driving or operating machinery. Always monitor your blood sugar levels.